Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients

Nutrition Research

Volumn 32, Issue 12, 2012, Pages 921-927

  Lemos, Joana R N ^a   Alencastro, Mariana Gascue de ^a   Konrath, Anita Vieceli ^b   Cargnin, Marina ^b   Manfro, Roberto Ceratti ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE DO VALE DO RIO DOS SINOS   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

C reactive protein; Clinical trial; Flaxseed oil; Hemodialysis; Human; Inflammation

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CALCIUM; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINSEED OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MINERAL OIL; PHOSPHORUS; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; DIETARY FATS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FLAX; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LINSEED OIL; MALE; MIDDLE AGED; PHYTOTHERAPY; RENAL DIALYSIS; SEEDS;

EID: 84870870832     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.08.007     Document Type: Article

References (47)

1. Pachaly M.A., Nascimento M.M., Suliman M.E., et al. Interleukin-6 is a better predictor of mortality as compared to C-reactive protein, homocysteine, pentosidine and advanced oxidation protein products in hemodialysis patients. Blood Purif 2008, 26(2):204-210.
2. Raj D.S., Carrero J.J., Shah V.O. Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis 2009, 54:990-992.
3. Pecoits-Filho R., Lindholm B., Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol Dial Transplant 2002, 17(Suppl. 11):28-31.
4. Snaedal S., Heimbürger O., Qureshi A.R., et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis 2009, 53(6):1024-1033.
5. Chmielewski M. Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk. Curr Opin Lipidol 2009, 1:3-9.
6. Suliman M.E., Stenvinkel P. Contribution of inflammation to vascular disease in chronic kidney disease patients. Saudi J Kidney Dis Transpl 2008, 19(3):329-345.
7. Brookhyser J. Omega 3 fatty acids. J Ren Nutr 2006, 16:c7-c10.
8. Weiss L.A., Barrett-Connor E., von Muhlen D. Ratio of n_6 to n_3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 2005, 81:934-938.
9. Harris W.S. Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?. Curr Atheroscler Rep 2004, 6:447.
10. Zabel R., Ash S., King N., et al. Gender differences in the effect of fish oil on appetite, inflammation and nutritional status in haemodialysis patients. J Hum Nutr Diet 2010, 23(4):416-425.
11. Szklarek-Kubicka M., Fijalkowska-Morawska J., Zaremba-Drobnik D., et al. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study. J Ren Nutr 2009, 19(6):487-493.
12. Ewers B., Riserus U., Marckmann P. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. J Ren Nutr 2009, 19(5):401-411.
13. Bowden R.G., Wilson R.L., Deike E., et al. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract 2009, 24(4):508-512.
14. Fiedler R., Mall M., Mall C., et al. Short-term administration of omega-3 fatty acid in hemodialysis patients with balanced lipid metabolism. J Ren Nutr 2005, 15:253-256.
15. Monahan D.J. High-octane (flaxseed oil) protein power shakes for patients on dialysis. J Ren Nutr 2007, 17:157-159.
16. Harris W.S., Assaad B., Poston W.C. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. Am J Cardiol 2006, 98:19i-26i.
17. DeLorgeril M., Salen P. Use and misuse of dietary fatty acids for the prevention and treatment of coronary heart disease. Reprod Nutr Dev 2004, 44:283-288.
18. Leanne T., Bloedon M.S., Philippe O., Szapary M.D. Flaxseed and cardiovascular risk. Nutr Rev 2008, 62:18-27.
19. Jenkins D.J., Kendall C.W., Vidgen E., et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measure and ex vivo androgen and progestin activity: a controlled cross-over trial. Am J Clin Nutr 1999, 69(3):395-402.
20. Yao Q., Axelsoon J., Stenvinkel P., et al. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nefrol 2004, 56:237-248.
21. Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 2001, 19:53-61.
22. Bayes B., Pastor M.C., Bonal J., et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant 2003, 18(1):106-112.
23. Yao Q., Lindholm B., Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial Int 2004, 8:118-129.
24. Herselman M., Esau N., Kruger J.M., et al. Relationship between body mass index and mortality in adults on maintenance hemodialysis: a systematic review. J Ren Nutr 2010, 20:281-292.
25. Mutsert R., Grootendorst D.C., Indemans F. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009, 19:127-135.
26. Yavuz A., Akbas S.H., Tuncer M., et al. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy. Transplant Proc 2004, 36:41-43.
27. Menon V., Wang X., Greene T., et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 2003, 42(1):44-52.
28. Kaysen G.A. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001, 12(7):1549-1557.
29. Beddhu S., Cheung A.K., Larive B., et al. Hemodialysis (HEMO) Study Group: inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients journal of renal nutrition. J Ren Nutr 2007, 17:372-380.
30. Kalantar-Zadeh K., Ikizler A., Block G., et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003, 42:864-881.
31. Yao Q., Axelsson J., Heimburger O., Stenvinkel P., Lindhom B. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nefrol 2004, 56:237-248.
32. Menon V., Greene T., Wang X., et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005, 68:766-772.
33. Nascimento M.M., Pecoits-Filho R., Qureshi A.R., et al. The prognostic impact fluctuating levels of C-reactive protein in Brazilians haemodialysis patients: a prospective study. Nephrol Dial Transplant 2004, 19:2803-2809.
34. Kehn P., Fernandes G. The importance of omega-3 fatty acids in the attenuation of immune-mediated diseases. J Clin Immunol 2001, 21:99-101.
35. Tapiero H., Nguyen G.B., Couvreur P., et al. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 2002, 56:211-215.
36. Mccord J.M., Edeas M.A. SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 2005, 50:139-144.
37. Calder P. n_3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(Suppl.):1505S-1519S.
38. Kris-Etherton P.M., Harris W.S., Lawrence J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
39. Murakami K., Sasaki S., Takahashi Y., Uenishi K., Yamasaki M., Hayabuchi H., Goda T., Oka J., Baba K., Ohki K., Muramatsu K., Sugiyama Y. Total n-3 polyunsaturated fatty acid intake is inversely associated with serum C-reactive protein in young Japanese women. Nutr Res 2008, 28(5):309-314.
40. Caughey G.E., Mantzioris E., Gibson R.A., et al. The effect on human tumor necrosis factor alpha and interleukin-1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996, 63:116-122.
41. Albert C.M., Jing M., Rifai N., et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002, 105:2595-2599.
42. Fassett R., Gobe G.C., Peake J.M., et al. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 2010, 56:728-742.
43. Lopez-Garcia E. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004, 134:1806-1811.
44. Ciubotaru I., Lee Y.S., Wander R. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003, 14:513-521.
45. Burdge G.C., Calder P.C. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005, 45:581-597.
46. Psota T., Gebauer S.K., Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular. Am J Cardiol 2006, 98:3-18.
47. Singer P., Berger L., Wirth M. Slow desaturation and elongation of linoleic and alpha-linolenic acid as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipidemic subjects. Prostaglandins Leukot Med 1986, 24:173-193.